Frazier Healthcare Partners is a leading provider of private equity and venture capital to healthcare companies. Founded in 1991, the firm has a long history of partnering with management teams to build market-leading businesses. Frazier focuses on investments in biopharmaceuticals, healthcare services, medical products, and related sectors. With over $8 billion of assets under management (AUM) across various funds, they employ a team of experienced investment professionals and operating partners with deep industry knowledge to support their portfolio companies in achieving growth and operational excellence. Their investment approach is characterized by a collaborative partnership model, aiming to create substantial long-term value.
The Seattle headquarters serves as the primary center for Frazier's investment operations, including deal sourcing, due diligence, portfolio company oversight, investor relations, and administrative functions.
Located in a prominent downtown Seattle high-rise, offering modern office amenities, collaborative workspaces, and panoramic views of the city and Puget Sound. The location provides easy access to the business district.
The work culture is typically fast-paced, analytical, and results-oriented, as expected in private equity. There's a strong emphasis on teamwork, deep healthcare industry expertise, and a commitment to ethical investment practices. Employees often describe it as intellectually stimulating and collaborative.
Seattle's strong healthcare, biotech, and research ecosystem makes it a strategic location for a healthcare-focused investment firm like Frazier. The headquarters' location facilitates networking with local industry leaders, academic institutions, and potential investment opportunities.
While Frazier Healthcare Partners' physical offices are in the United States (Seattle and Menlo Park), their investment scope is primarily North America and selectively Europe. They support portfolio companies that may have global operations, sales, or clinical trials, thus their influence and oversight extend internationally through these investments. They often partner with management teams to scale businesses globally.
601 Union Street, Suite 3200
Seattle
WA
USA
Address: 2882 Sand Hill Road, Suite 110, Menlo Park, CA 94025
To maintain a strong presence in Silicon Valley, fostering relationships with entrepreneurs, research institutions, other VCs, and tapping into the rich talent pool and cutting-edge advancements in the Bay Area's life sciences sector.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Frazier Healthcare Partners' leadership includes:
Frazier Healthcare Partners has been backed by several prominent investors over the years, including:
Frazier Healthcare Partners regularly strengthens its team through strategic hires and internal promotions. Over the past year, they have continued to build out their investment professional ranks and operating partner network. Public announcements are typically focused on Partner-level changes or significant additions to their specialized teams.
Discover the tools Frazier Healthcare Partners uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Frazier Healthcare Partners primarily uses the email format [first_initial][last]@[domain] or [first].[last]@[domain]. For example, Jane Doe would likely be jdoe@frazierhealthcare.com or jane.doe@frazierhealthcare.com.
flast@frazierhealthcare.com (e.g., jdoe@frazierhealthcare.com) and first.last@frazierhealthcare.com (e.g., jane.doe@frazierhealthcare.com)
Format
nnaini@frazierhealthcare.com
Example
90%
Success rate
Frazier Healthcare Partners Website • January 24, 2024
Frazier Healthcare Partners announced the promotions of Christina Ge and Ryan Lucero to Partner on the Growth Buyout team. These promotions recognize their significant contributions to the firm and its portfolio companies....more
Frazier Healthcare Partners Website • August 1, 2023
Frazier Healthcare Partners announced that Michael Davitian, M.D., has joined the firm as a Principal on the Life Sciences team. Dr. Davitian was previously a Principal at Blackstone Life Sciences....more
PR Newswire • May 9, 2023
Frazier Healthcare Partners announced the closing of Frazier Life Sciences XII (FLS XII), L.P., significantly oversubscribed at its $1.2 billion hard cap. FLS XII will continue Frazier's 32-year strategy of investing in innovative therapeutics companies....more
Business Wire • July 12, 2023
Funds managed by affiliates of Apollo announced they have entered into a definitive agreement to acquire a majority interest in a 21st Century Oncology joint venture from Lifepoint Health. 21st Century Oncology is a portfolio company of Frazier Healthcare Partners....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Frazier Healthcare Partners, are just a search away.